Mumbai, May 12 -- The Agency with their designated investigator inspected the facility from 5th to 9th May 2025.

The inspection established that the site is in an "Acceptable State of Compliance" with Zero Form 483 inspectional observations from US FDA.

Commenting on the inspection outcome, Sandeep Rao, MD & CEO said, "We are very happy with the successful inspection outcome of our Ambernath API site with Zero 483 inspectional observations. This is the third (3rd) consecutive successful inspection outcome, with Zero 483 inspectional observations, across the Solara network of manufacturing facilities. The inspection outcome demonstrates our commitment to regulatory excellence at our global manufacturing sites and relentless focus on worl...